A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis

• DOI: 10.1016/j.cgh.2024.11.013
• Publication Date: 2024-12-16T21:04:40Z
• Authors: Silvio Danese; Michael E. Rothen...; Jeremy J. Lim; Han Ting Ding; Jacqueline M. McB...; Yiling Chen; Ajit Dash; Jordan S. Mar; Mary Keir; Laurent Peyrin-Bi...; Julian Panes; Jean-Frederic Col...; Brian Feagan; John F. Valentine; Stefan Schreiber